SCHEMBL18784232

SCHEMBL18784232

CCN(CC)CCNc1ccccc1CS(=O)(=O)Cc1ccc(-c2ccoc2)c(OC)c1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 13/20 0.47
FABP4 P15090 1/20 0.35
FABP5 Q01469 1/20 0.35
TOP2A P11388 1/20 0.34
TOP2B Q02880 1/20 0.34
TERT O14746 1/20 0.33
CYP3A4 P08684 2/20 0.31
CYP2C9 P11712 2/20 0.31
CHEK1 O14757 1/20 0.31
PIM1 P11309 1/20 0.31
IDO1 P14902 1/20 0.31
LTK P29376 1/20 0.31
LIMK1 P53667 1/20 0.31
CLK4 Q9HAZ1 1/20 0.31
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1648655 0.89 METAP2 (0.48) METAP2FABP4FABP5
SCHEMBL18801044 0.85 METAP2 (0.44) METAP2FABP4FABP5TOP2ATOP2B
SCHEMBL1649183 0.85 METAP2 (0.52) METAP2FABP4FABP5
SCHEMBL1648156 0.83 METAP2 (0.43) METAP2FABP4FABP5TOP2ATOP2B
SCHEMBL1648930 0.80 METAP2 (0.47) METAP2FABP4FABP5
SCHEMBL18784222 0.80 METAP2 (0.41) METAP2FABP4FABP5CYP3A4CYP2C9
SCHEMBL18801365 0.78 METAP2 (0.39) METAP2TOP2ATOP2BTERTCYP3A4
SCHEMBL1648326 0.78 METAP2 (0.47) METAP2FABP4FABP5TERTMAPT
SCHEMBL1648737 0.78 METAP2 (0.46) METAP2FABP4FABP5ALDH1A1KDM4E
SCHEMBL1647756 0.76 METAP2 (0.53) METAP2FABP4FABP5ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2486004-B1 SULPHONE COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY ZAFGEN INC (US) 2017-05-03 EP claimed